Revenue: As of FY2026 Q1, the actual value is USD 745.6 M.EPS: As of FY2026 Q1, the actual value is USD 0.78, missing the estimate of USD 1.2369.EBIT: As of FY2026 Q1, the actual value is USD 90.48 M.<h3>First Quarter 2026 Financial Highlights</h3>ESAB Corporation reported record first quarter sales of $746 million, marking a 10% increase on a reported basis, though core organic sales decreased by 1% compared to the prior year . Net income from continuing operations attributable to ESAB was $50 million, with core adjusted net income reaching $80 million, representing a 5% year-over-year increase . Core adjusted EBITDA was $136 million, up 6%, but the core adjusted EBITDA margin decreased by 80 basis points year-over-year to 19.0% .<h4>Consolidated Statements of Operations (Three Months Ended April 3, 2026 vs. April 4, 2025)</h4><ul><li>Net sales: $745,597 thousand for April 3, 2026, compared to $678,138 thousand for April 4, 2025 .</li><li>Cost of sales: $470,485 thousand for April 3, 2026, compared to $422,936 thousand for April 4, 2025 .</li><li>Gross profit: $275,112 thousand for April 3, 2026, compared to $255,202 thousand for April 4, 2025 .</li><li>Selling, general and administrative expense: $174,472 thousand for April 3, 2026, compared to $140,858 thousand for April 4, 2025 .</li><li>Restructuring and other related charges: $10,161 thousand for April 3, 2026, compared to $4,499 thousand for April 4, 2025 .</li><li>Operating income: $90,479 thousand for April 3, 2026, compared to $109,845 thousand for April 4, 2025 .</li><li>Interest expense and other, net: $25,577 thousand for April 3, 2026, compared to $16,782 thousand for April 4, 2025 .</li><li>Income from continuing operations before income taxes: $64,902 thousand for April 3, 2026, compared to $93,063 thousand for April 4, 2025 .</li><li>Income tax expense: $13,111 thousand for April 3, 2026, compared to $20,499 thousand for April 4, 2025 .</li><li>Net income from continuing operations: $51,791 thousand for April 3, 2026, compared to $72,564 thousand for April 4, 2025 .</li><li>Loss from discontinued operations, net of taxes: -$2,554 thousand for April 3, 2026, compared to -$2,732 thousand for April 4, 2025 .</li><li>Net income: $49,237 thousand for April 3, 2026, compared to $69,832 thousand for April 4, 2025 .</li><li>Income attributable to noncontrolling interest, net of taxes: -$1,593 thousand for April 3, 2026, compared to -$2,469 thousand for April 4, 2025 .</li><li>Net income attributable to ESAB Corporation: $47,644 thousand for April 3, 2026, compared to $67,363 thousand for April 4, 2025 .</li></ul><h4>Adjusted Net Income (Non-GAAP) (Three Months Ended April 3, 2026 vs. April 4, 2025)</h4><ul><li>Adjusted net income from continuing operations: $79.0 million for April 3, 2026, compared to $80.7 million for April 4, 2025 .</li><li>Core adjusted net income from continuing operations: $80.4 million for April 3, 2026, compared to $76.9 million for April 4, 2025 .</li><li>Adjusted net income margin from continuing operations: 10.6% for April 3, 2026, compared to 11.9% for April 4, 2025 .</li></ul><h4>Adjusted EBITDA (Non-GAAP) (Three Months Ended April 3, 2026 vs. April 4, 2025)</h4><ul><li>Adjusted EBITDA: $136.6 million for April 3, 2026, compared to $133.9 million for April 4, 2025 .</li><li>Core adjusted EBITDA: $135.9 million for April 3, 2026, compared to $127.9 million for April 4, 2025 .</li><li>Adjusted EBITDA margin: 18.3% for April 3, 2026, compared to 19.7% for April 4, 2025 .</li><li>Core adjusted EBITDA margin: 19.0% for April 3, 2026, compared to 19.8% for April 4, 2025 .</li></ul><h4>Sales Growth (Three Months Ended April 3, 2026 vs. April 4, 2025)</h4><ul><li>Total ESAB Sales Growth: Total sales growth was 9.9%, comprising organic sales growth of -1.9%, acquisitions contributing 6.3%, and foreign currency translation impacting by 5.5% .</li><li>Americas Sales Growth: Total sales growth was 2.7%, with organic sales growth of -0.7%, no acquisition impact, and foreign currency translation contributing 3.5% .</li><li>EMEA &amp; APAC Sales Growth: Total sales growth was 15.0%, with organic sales growth of -2.7%, acquisitions contributing 10.8%, and foreign currency translation contributing 6.9% .</li></ul><h4>Core Sales Growth (Three Months Ended April 3, 2026 vs. April 4, 2025)</h4><ul><li>Total ESAB Core Sales Growth: Total core sales growth was 10.5%, comprising core organic sales growth of -1.1%, acquisitions contributing 6.6%, and foreign currency translation impacting by 5.0% .</li><li>Americas Core Sales Growth: Total core sales growth was 2.7%, with core organic sales growth of -0.7%, no acquisition impact, and foreign currency translation contributing 3.5% .</li><li>EMEA &amp; APAC Core Sales Growth: Total core sales growth was 16.4%, with core organic sales growth of -1.5%, acquisitions contributing 11.7%, and foreign currency translation contributing 6.1% .</li></ul><h4>Cash Flow (Three Months Ended April 3, 2026 vs. April 4, 2025)</h4><ul><li>Net cash provided by operating activities: $46.9 million for April 3, 2026, compared to $35.4 million for April 4, 2025 .</li><li>Purchases of property, plant and equipment: -$13.7 million for April 3, 2026, compared to -$7.3 million for April 4, 2025 .</li><li>Adjusted free cash flow: $39.5 million for April 3, 2026, compared to $30.4 million for April 4, 2025 .</li></ul><h3>Full Year 2026 Outlook</h3>ESAB Corporation reiterates its full-year 2026 outlook, projecting total core sales growth of 6.0% to 9.0%, with core organic sales growth expected to be between 2.0% and 4.0% . The company forecasts core adjusted EBITDA to be between $575 million and $595 million, and core adjusted EPS to range from $5.70 to $5.90 . This guidance excludes any impact from the Eddyfi acquisition or its related financing .

Esab | 8-K: FY2026 Q1 Revenue: USD 745.6 M